These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1889183)

  • 1. In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.
    Yamane N; Jones RN
    Diagn Microbiol Infect Dis; 1991; 14(4):337-45. PubMed ID: 1889183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.
    Swenson JM; Facklam RR; Thornsberry C
    Antimicrob Agents Chemother; 1990 Apr; 34(4):543-9. PubMed ID: 2344161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of glycopeptides against vancomycin-resistant gram-positive bacteria.
    Nicas TI; Cole CT; Preston DA; Schabel AA; Nagarajan R
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1477-81. PubMed ID: 2817848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to vancomycin and teicoplanin: an emerging clinical problem.
    Johnson AP; Uttley AH; Woodford N; George RC
    Clin Microbiol Rev; 1990 Jul; 3(3):280-91. PubMed ID: 2143434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT; Schønheyder H; Pers C; Thomsen VF
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
    Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
    Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
    Biavasco F; Vignaroli C; Lupidi R; Manso E; Facinelli B; Varaldo PE
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
    Collins LA; Eliopoulos GM; Wennersten CB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1364-6. PubMed ID: 8328787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolates.
    Barrett MS; Wenzel RP; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(7):641-4. PubMed ID: 1424522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.
    de la Maza L; Ruoff KL; Ferraro MJ
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1383-4. PubMed ID: 2552910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.
    Fraise AP; Andrews J; Wise R
    J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoparcin, a glycopeptide used in animal foods: antimicrobial spectrum and potency tested against human isolates from the United States.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):241-8. PubMed ID: 9458981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium.
    el-Mady A; Mortensen JE
    Diagn Microbiol Infect Dis; 1991; 14(2):141-5. PubMed ID: 1651825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of sparfloxacin (AT-4140 and CI-978), a new quinolone antimicrobial agent, against Haemophilus and gram-positive cocci.
    Rudrik JT; Ferrigno SR; Gee SL
    Diagn Microbiol Infect Dis; 1991; 14(4):355-60. PubMed ID: 1889186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
    Pfaller MA; Mendes RE; Sader HS; Castanheira M; Flamm RK
    J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
    Collins LA; Malanoski GJ; Eliopoulos GM; Wennersten CB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):598-601. PubMed ID: 8460927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.